Atlas FDA

Alinity i AFP Reagent Kit

FDA premarket approval P120008/S026 · decided 2023-11-08

Approval details

PMA number
P120008
Supplement
S026
Supplement type
Real-Time Process
Supplement reason
Change Design/Components/Specifications/Material
Trade name
Alinity i AFP Reagent Kit
Generic name
KIT, TEST, ALPHA-FETOPROTEIN FOR NEURAL TUBE DEFECTS
Applicant
Abbott Laboratories
Date received
2023-08-11
Decision date
2023-11-08
Days to decision
89 days
Decision code
APPR
Product code
LOK
Advisory committee
Immunology
Expedited review
No
Location
Abbott Park, IL
Statement
Approval for the release of Alinity i AFP for use with Alinity i (Alinity ci-series single and multimodule configuration) when connected to the GLP systems Track.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Anti-HCV Next (K252424)Abbott Laboratories2026-04-28
ARCHITECT iGentamicin (K243500)Abbott Laboratories2025-07-09
Alinity i Rubella IgG (K243168)Abbott Laboratories2025-06-20
Alinity h-series System (K243283)Abbott Laboratories2025-02-20
Alinity i Toxo IgM (K233932)Abbott Laboratories2024-08-30
TBI (K232669)Abbott Laboratories2023-09-29
HAVAb IgG II (K222850)Abbott Laboratories2023-08-10
Alinity h-series System (K220031)Abbott Laboratories2023-08-04